Similar articles

• Melanoma: from darkness to promise.

  Gasent Blesa JM, Grande Pulido E, Alberola Candel V, Provencio Pulla M. Gasent Blesa JM, et al. Am J Clin Oncol. 2011 Apr;34(2):179-87. doi: 10.1097/COC.0b013e3181d6b427. Am J Clin Oncol. 2011. PMID: 20498590 Review.
• The conquest of melanoma by immunotherapy.

  Lejeune FJ. Lejeune FJ. Melanoma Res. 2015 Oct;25(5):373-5. doi: 10.1097/CMR.0000000000000178. Melanoma Res. 2015. PMID: 26173006 No abstract available.
• Advances in the treatment of late stage melanoma.

  Walkington LA, Lorigan P, Danson SJ. Walkington LA, et al. BMJ. 2013 Mar 4;346:f1265. doi: 10.1136/bmj.f1265. BMJ. 2013. PMID: 23460638 No abstract available.
• Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.

  Gaudy-Marqueste C, Dussouil AS, Carron R, Troin L, Malissen N, Loundou A, Monestier S, Mallet S, Richard MA, Régis JM, Grob JJ. Gaudy-Marqueste C, et al. Eur J Cancer. 2017 Oct;84:44-54. doi: 10.1016/j.ejca.2017.07.017. Epub 2017 Aug 4. Eur J Cancer. 2017. PMID: 28783540
• [Immunotherapy of melanoma].

  Dréno B. Dréno B. Bull Acad Natl Med. 2010 Oct;194(7):1373-81. Bull Acad Natl Med. 2010. PMID: 22043632 Review. French.